In particular, BCR-ABL expression during development of embryonic stem cells causes expansion of multipotent and myeloid progenitors, which could be the potential cell of origin responding to BCR-ABL induced CML [79]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.